Brimonidine (Brimonidine Tartrate Ophthalmic) - Summary

BRIMONIDINE SUMMARY

BRIMONIDINE TARTRATE
ophthalmic solution, 0.2%
sterile

Brimonidine tartrate ophthalmic solution 0.2% is a relatively selective alpha-2 adrenergic agonist for ophthalmic use.

Brimonidine tartrate ophthalmic solution is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The IOP lowering efficacy of Brimonidine tartrate ophthalmic solution diminishes over time in some patients. This loss of effect appears with a variable time of onset in each patient and should be closely monitored.

See all Brimonidine indications & dosage >>

BRIMONIDINE NEWS HIGHLIGHTS

Media Articles Related to Brimonidine ( Ophthalmic)

General Opital Council News - 20th November, 2008
Source: Eye Health / Blindness News From Medical News Today [2008.11.20]

NHS Sight Tests Top 11 Million After 14 Per Cent Rise Since 2002-03, Report Shows, England
Source: Eye Health / Blindness News From Medical News Today [2008.11.20]

Experimental Drug RGN-259 Promotes Healing In Patients With Non-Healing Corneal Ulcers - Four Patients Treated Under "Compassionate Use" IND
Source: Eye Health / Blindness News From Medical News Today [2008.11.18]

New Research Into Drug Delivery To Treat Eye Disease Highlighted By Conference Report
Source: Eye Health / Blindness News From Medical News Today [2008.11.18]

American Academy Of Ophthalmology Joint Meeting Marked By Strong Turnout And Rich Scientific Program
Source: Eye Health / Blindness News From Medical News Today [2008.11.12]

more >>

Published Studies Related to Brimonidine ( Ophthalmic)

Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. [2008.07.08]

Meta-analysis of randomized controlled trials comparing timolol with brimonidine in the treatment of glaucoma. [2008.04]

Cyclosporine 0.05% ophthalmic preparation to aid recovery from loss of corneal sensitivity after LASIK. [2008.04]

Ocular Penetration and Pharmacokinetics of Topical Gatifloxacin 0.3% and Moxifloxacin 0.5% Ophthalmic Solutions After Keratoplasty. [2008.04]

Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2%pirenzepineophthalmicgelinchildrenwithmyopia. [2008.03.21]

more >>

Clinical Trials Related to Brimonidine ( Ophthalmic)

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Completed]

Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs [Completed]

Study of Medical Treatment of Low-Pressure (Normal Tension) Glaucoma [Completed]

Absorption of Brimonidine Ophthalmic Solution in the Aqueous Humor of Cataract Patients [Completed]

Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients [Completed]

more >>